From: "Melba Lay" <zfimrvnoh@chez.com>
To: <paliourg@iit.demokritos.gr>
Subject: entourage,St0ckMogul Newsletter
Date: Mon, 30 Aug 2004 00:26:39 +0300
MIME-Version: 1.0
Content-Type: text/html;
	charset="iso-8859-7"
Content-Transfer-Encoding: quoted-printable
X-Priority: 3
X-MSMail-Priority: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2527

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
Ralph Velez,<p>


Genex Pharmaceutical, Inc.(OTCBB: GENX)<p>
                                 =20
              Biotech Sizzle with Sales and Earnings!<p>
                                 =20
              Treating Bone Related Injuries in China<p>

Revenues three months ended June 30, 2004: $525,750 vs. $98,763 year
ago period<p>

Net  INC0ME  three  months  ended  June  30,  2004:   $151,904   vs.
($23,929)year ago period (Source: 10Q 8/16/04)<p>

Look how these Chinese  Companies  trading  in  the USA did and what
they would've made your portfolio look like if you had the scoop  on
them:   (Big  M0NEY  Was Made in These Stocks by Savvy Investors Who
Timed Them Right)<p>

(OTCBB:CAAS):Closed September 2, 2003  at $4.00. Closed December 31,
2003: $16.65, Up 316%<p>

OTCBB:CWTD):Closed January 30, 2004  at  $1.50. Closed February 17th
at $7.90, Up 426%<p>

Ordinary Investors Like You are Getting Filthy,  Stinking  Ri'ch  in
Tiny Stocks No One has Ever Heard of Until Now.<p>

This  Biotech  Bad  Boy (GENX) is already out of Stealth Mode and is
top line revenue producing! Do you  see where we're going with this?
Biotech Sizzle with Sales and Earnings!<p>
       =20
About  Genex  Pharmaceutical,  Inc.  (Product  Distribtued  to   400
Hospitals in 22 Provinces)<p>

Genex  Pharmaceutical,  Inc. is a biomedical technology company with
distinctive proprietary  technology  for  an  orthopedic device that
treats bone-related injuries. Headquartered in Tianjin,  China,  the
Company  manufactures  and  distributes Reconstituted Bone Xenograft
(RBX), to 400 hospitals  in  22 provinces throughout mainland China.
RBX is approved by the State Food and Drug Administration (SFDA)  in
China  (the  Chinese  government  agency  that  regulates  drugs and
medical devices). RBX  offers  a  modern  alternative to traditional
methods of  treating  orthopedic  injuries.  (Source:  News  Release
7/27/04)<p>

Recent  Press  Release  Headlines:  (New  Product  Tested  and Large
Acquisition in the Works!)<p>

*Genex   Pharmaceutical    Adopts    New   Proprietary   Technology,
Substantially Reduces Manufacturing Costs, Sees Positive  Impact  to
Earnings<p>

*Genex Pharmaceutical Signs Letter of  Intent  to Acquire One of the
World's Largest Producers of Vitamin B1<p>

*Genex Pharmaceutical Sees Strong Earnings Growth for 2004 and  2005<p>

*Genex Pharmaceutical 2nd Quarter Revenue Up 432%, Gross  PR0FIT  Up
380%,  Net  INC0ME  Soars,  Sees  Continued  Earnings  Momentum  for
Remainder of 2004<p>

*Genex  Pharmaceutical's  Micro-Particle RBX Medical Product Expands
to the Dental Markets<p>

*Could this be a  "Rising  Star  Stock"  for your portfolio? You may
easily agree that the company is doing some dynamic things. Some  of
these small stocks have absolutely EXPLODED in price recently.<p>

*You  may  want  to  consider the "Chinese Fortune Cookie" Strategy:
Rising Star Chinese Companies  trading  in  the US.. Consider adding
GENX to your portfolio today!<p>
                       =20
DIS-CLAIMER:   Information  within  this  ema-il  contains  "F0RWARD
looking  statements"  within  the  meaning  of  Section  27A  of the
Securities Act of 1933 and Section 21B of  the  Securities  Exchange
Act of 1934. Any statements that express or involve discussions with
respect  to  predictions, expectations, beliefs, plans, projections,
objectives, goals, assumptions or  future  events or performance are
not statements of  historical  fact  and  may  be  "F0RWARD  looking
statements."F0RWARD  looking  statements  are based on expectations,
estimates and projections at the  time  the statements are made that
involve a number of risks and uncertainties which could cause actual
results  or  events  to  differ  materially  from  those   presently
anticipated.   F0RWARD  looking  statements  in  this  action may be
identified through the use  of  words such as "projects", "foresee",
"expects",   "will,"   "anticipates,"    "estimates,"    "believes,"
"understands"  or  that  by  statements  indicating  certain actions
"may," "could," or "might"  occur.   As  with many micro-cap stocks,
today's company has additional  risk  factors  worth  noting.  Those
factors  include: a limited operating history: the company advancing
cash to related parties and a shareholder on an unsecured basis: one
vendor, a related  party  through  a  majority stockholder, supplies
ninety-seven percent of the company's raw materials: reliance on two
customers for over fifty percent  of  their  business  and  numerous
related  party transactions and the need to raise capital.These risk
factors and others are fully  detailed in the company's SEC filings.
We urge you to read them before you invest. The  Publisher  of  this
letter  does  not  represent  that the information contained in this
message states all material facts  or  does not omit a material fact
necessary  to  make  the  statements  therein   not   misleading.All
information  provided  within  this  ema-il pertaining to investing,
ST0CKS or securities must be  understood as information provided and
not investment advice. The Publisher  of  this  letter  advises  all
readers   and   subscribers   to   seek  advice  from  a  registered
professional securities representative  before  deciding to trade in
stocks featured within this ema-il.  None  of  the  material  within
this  report  shall be construed as any kind of investment advice or
solicitation.  Many  of  these   companies   are  on  the  verge  of
bankruptcy.  You can lose all your money by investing in this stock.
The Publisher of this letter is not a registered investment ADVIS0R.
Subscribers should  not  view  information  herein  as  legal,  tax,
accounting   or   investment   advice.   Any   reference   to   past
performance(s)  of companies are specially selected to be referenced
based on the favorable  performance  of  these companies.  You would
need perfect timing to acheive the results in  the  examples  given.
There  can  be no assurance of that happening.  Remember, as always,
past  performance  is  never  indicative  of  future  results  and a
thorough due diligence effort, including a  review  of  a  company's
filings,  should  be  completed  prior to investing.The Publisher of
this letter has no  relationship  with  CAAS  and CWTD.  (Source for
Price Information:Yahoo Finance Historical). In compliance with  the
Securities  Act  of  1933, Section17(b),The Publisher of this letter
discloses the receipt of twenty  four  thousand dollars from a third
party,(DMI, Inc) not an officer, director or  affiliate  shareholder
for the circulation of this report. Be aware of an inherent conflict
of  interest  resulting  from such compensation due to the fact that
this is a paid adver-tisement  and  is not without bias. All factual
information  in  this  report  was  gathered  from  public  sources,
including but not limited  to  Company  Websites,  SEC  Filings  and
Company  Press Releases.  The Publisher of this letter believes this
information to be reliable  but  can  make  no  guar-antee as to its
accuracy or completeness. Use of the  material  within  this  ema-il
constitutes your acceptance of these terms.<p>


indemnity urbanite fogy denude registrable usia pilfer ethylene pounce =
pisces mutate water dialect contrast seymour molest commonality =
epidermic liquefaction prom koenig cookbook clio sixteenth casteth =
barrage borax told irredeemable desmond circle ,finch parch farkas fum =
arrogant neumann remission marten countryside silty bird placenta =
diphthong crass typhoid eyesight diatom extendible clip midspan =
insomniac continuation .woebegone borealis pyramidal brandish sepal =
abnormal career avertive verdict bath collie canal rpm jolly primeval =
wong dishwasher noose magician accentuate apparel apache aerogene =
palmetto halsey rosetta springy despot depend sloe cattleman beginner =
exorcise cranberry von dissonant .<p>
